Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
Hormone and Metabolic Research · 01.08.2023 · 55 (08) · 511-519
DOI: 10.1055/a-2112-1596 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.08.2023. Verfasst von Haodong Liang und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated TCM Hospital of Guangzhou Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Glucocorticoids, Osteoporosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Technology Project of Guangzhou, Administration of Traditional Chinese Medicine of Guangdong Province.
Abstract (Originalsprache)
There is still a lack of high-quality evidence-based studies on the efficacy of drug treatment for glucocorticoid-induced osteoporosis (GIOP). The purpose of this umbrella review is to comprehensively evaluate the existing evidence to determine the efficacy and safety of pharmacological interventions for GIOP. We searched PubMed, Embase, and the Cochrane Library for systematic reviews and/or meta-analyses (SRs) of randomized controlled trials (RCTs) aimed at evaluating drug therapy for GIOP. Both the methodological quality and the strength of recommendation of the endpoints included in the SRs were evaluated by using the AMSTAR-2 tool and GRADE system, respectively. Six SRs involving 7225 GIOP patients in 59 RCTs were included in this umbrella review. The results of the methodological quality evaluation showed that 2 high-quality, 2 low-quality and 2 critically low-quality SRs were included. The GRADE evaluation results showed that the quality of evidence and the strength of recommendation of 46 outcome indicators were evaluated in the umbrella review; there were 3 with high-level evidence, 20 with moderate-level evidence, 15 with low-level evidence, and 8 with very low-level evidence. Moderate- to high-level evidence suggests that teriparatide, bisphosphonates, and denosumab can improve the bone mineral density in patients with GIOP. The findings of this umbrella review can enable patients and clinical healthcare professionals to choose the best drug prescription.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Affiliated TCM Hospital of Guangzhou Medical University, Guangzhou, China.
Förderung
- Health Technology Project of Guangzhou
- Administration of Traditional Chinese Medicine of Guangdong Province
Zitieren
APA
Liang, H., Zhao, J., & Tian, T. (2023). Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review. Hormone and Metabolic Research, 55(08), 511-519. https://doi.org/10.1055/a-2112-1596
Vancouver
Liang H, Zhao J, Tian T. Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review. Hormone and Metabolic Research. 2023;55(08):511-519. doi:10.1055/a-2112-1596
BibTeX
@article{Liang2023,
author = {Liang, Haodong and Zhao, Jinlong and Tian, Tianzhao},
title = {Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review},
journal = {Hormone and Metabolic Research},
year = {2023},
volume = {55},
number = {08},
pages = {511--519},
doi = {10.1055/a-2112-1596}
}
EUVIMED